We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 6,994 results
  1. Psychotic Disorders (“Schizophrenia”)

    After reading the chapter, the reader should be able to name the symptoms of schizophrenia as well as its treatment options and to classify different...
    Florian Schlagenhauf, Philipp Sterzer in Psychoneuroscience
    Chapter 2023
  2. Nonlinear Methods for the Investigation of Psychotic Disorders

    The basic aspects of nonlinear dynamics theory’s utility and impact on understanding psychotic disorders are reviewed and discussed in this chapter....
    Alexandra Korda, Marina Frisman, ... Stefan Borgwardt in Computational Neuroscience
    Protocol 2023
  3. Brain volume in chronic ketamine users — relationship to sub-threshold psychotic symptoms and relevance to schizophrenia

    Rationale

    Ketamine may model aspects of schizophrenia arising through NMDA receptor activity deficits. Although acute ketamine can induce effects...

    Robert A. Chesters, Fiona Pepper, ... James M. Stone in Psychopharmacology
    Article Open access 06 July 2021
  4. Inter-rater reliability of subthreshold psychotic symptoms in individuals with 22q11.2 deletion syndrome

    Background

    Pathways leading to psychosis in 22q11.2 deletion syndrome (22q11.2DS) have been the focus of intensive research during the last two...

    Tyler M. Moore, Deby Salzer, ... Doron Gothelf in Journal of Neurodevelopmental Disorders
    Article Open access 14 June 2021
  5. Brain metabolite levels in remitted psychotic depression with consideration of effects of antipsychotic medication

    Background

    The neurobiology of psychotic depression is not well understood and can be confounded by antipsychotics. Magnetic resonance spectroscopy...

    Hideaki Tani, Iska Moxon-Emre, ... Aristotle N. Voineskos in Brain Imaging and Behavior
    Article Open access 02 November 2023
  6. Blood and CSF anti-neuronal antibodies testing in psychotic syndromes: a retrospective analysis from a tertiary psychiatric hospital

    A Consensus of Psychoimmunology Experts ( Pollak et al., 2019) established a set of red flags and proposed diagnostic criteria for psychosis of...

    Joana Lopes, Maria João Malaquias, ... Ana Paula Correia in Immunologic Research
    Article 31 January 2024
  7. A Pilot Study of Adolescents with Psychotic Experiences: Potential Cerebellar Circuitry Disruption Early Along the Psychosis Spectrum

    A berrant connectivity in the cerebellum has been found in psychotic conditions such as schizophrenia corresponding with cognitive and motor deficits...

    Caoimhe Gaughan, Anurag Nasa, ... Darren William Roddy in The Cerebellum
    Article Open access 23 June 2023
  8. Associations between long-term psychosis risk, probabilistic category learning, and attenuated psychotic symptoms with cortical surface morphometry

    Neuroimaging studies have consistently found structural cortical abnormalities in individuals with schizophrenia, especially in structural hubs....

    Jessica P. Y. Hua, Nicole R. Karcher, ... John G. Kerns in Brain Imaging and Behavior
    Article 04 July 2021
  9. QEEG and ERP Biomarkers of Psychotic and Mood Disorders and Their Treatment Response

    Electroencephalography (EEG) is widely accessible and can be relatively easily applied in clinical settings. This chapter is focused on selected...
    Sevdalina Kandilarova, Igor Riečanský in Computational Neuroscience
    Protocol 2023
  10. Efficacy of probiotic supplements in improving the symptoms of psychosis, anxiety, insomnia, and anorexia due to amphetamine and methamphetamine use: a randomized clinical trial

    Rationale

    Changes in the density and diversity of gut microbiota in chronic use of methamphetamine have been mentioned as contributors to psychotic...

    Rahim Badrfam, Atefeh Zandifar, ... Mahboobeh Mehrabani Natanzi in Psychopharmacology
    Article 21 March 2024
  11. White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseases

    Background

    Neuropsychiatric symptoms (NPS) are a core feature of most neurodegenerative and cerebrovascular diseases. White matter hyperintensities...

    Miracle Ozzoude, Brenda Varriano, ... Maria Carmela Tartaglia in Alzheimer's Research & Therapy
    Article Open access 20 June 2023
  12. Striatal dopamine synthesis capacity and its association with negative symptoms upon resolution of positive symptoms in first-episode schizophrenia and delusional disorder

    Rationale

    How striatal dopamine synthesis capacity (DSC) contributes to the pathogenesis of negative symptoms in first-episode schizophrenia (SZ) and...

    Stephanie M. Y. Wong, Y. N. Suen, ... Eric Y. H. Chen in Psychopharmacology
    Article 25 February 2022
  13. Neuronal pentraxin-2 (NPTX2) serum levels during an acute psychotic episode in patients with schizophrenia

    Background

    Neuronal pentraxin-2 (NPTX2, an immediate-early gene), which regulates synapse activity and neuroplasticity, plays an essential role in the...

    Diğdem Göverti, Nihan Büyüklüoğlu, ... Erol Göka in Psychopharmacology
    Article 28 April 2022
  14. Psychotic Disorders in the Veterans of Local Wars

    Objectives. To determine the frequency of leading psychopathological syndromes, dynamics, and comorbidities of schizophrenia and other endogenous...

    A. M. Reznik, T. S. Syunyakov, ... Yu. L. Martynyuk in Neuroscience and Behavioral Physiology
    Article 18 February 2021
  15. Psychotic Disorders in Epilepsy: Do They Differ from Primary Psychosis?

    Any attempt to compare the definitions of symptoms listed for “primary psychoses” with those adopted in studies of psychoses in patients with...
    Chapter 2021
  16. Genetic Basis of Psychotic Illnesses: A Comprehensive Overview

    Psychotic illness is a major health burden at the present world. Common psychotic disorders like autism spectrum disorders and schizophrenia...
    Md. Abdul Aziz, Tahmina Akter, ... Mohammad Safiqul Islam in Autism Spectrum Disorder and Alzheimer's Disease
    Chapter 2021
  17. Sex differences in neuropsychiatric symptoms in Alzheimer’s disease dementia: a meta-analysis

    Background

    Neuropsychiatric symptoms (NPS) are common in individuals with Alzheimer’s disease (AD) dementia, but substantial heterogeneity exists in...

    Willem S. Eikelboom, Michel Pan, ... Janne M. Papma in Alzheimer's Research & Therapy
    Article Open access 04 April 2022
  18. Psychedelic use and psychiatric risks

    Rationale

    Research on psychedelics has recently shown promising results in the treatment of various psychiatric disorders, but relatively little...

    Otto Simonsson, Simon B. Goldberg, ... Peter S. Hendricks in Psychopharmacology
    Article Open access 24 October 2023
  19. Study of the Association between Oxytocin Receptor Gene Polymorphism, Childhood Adversity, and Negative Symptoms of Schizophrenia

    Abstract

    It is known that the neurohormone oxytocin plays an important role in the pathogenesis of mental illness and also models the relationship...

    T. V. Lezheiko, V. A. Mikhailova, ... V. E. Golimbet in Russian Journal of Genetics
    Article 01 March 2024
  20. A systematic review and meta-analysis of synthetic cathinone use and psychosis

    Rationale

    Synthetic cathinones (SC), commonly referred to as “bath salts”, are stimulants resembling the natural alkaloid cathinone found in the khat ...

    Rishika R. Daswani, Cassandra M. Choles, ... Alasdair M. Barr in Psychopharmacology
    Article 06 March 2024
Did you find what you were looking for? Share feedback.